Trial Profile
A Multicenter, Open-Label, Randomized Study to Assess the Metabolics, Efficacy, and Safety of Once-Daily Darunavir Versus Atazanavir in HIV-Infected Treatment-Naive Adult Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Darunavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms METABOLIK
- Sponsors Tibotec Inc
- 26 Feb 2016 Results of substudy published in the HIV Clinical Trials
- 13 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 17 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.